A colorectal cancer blood test candidate from Exact Sciences fell short in its pivotal study, but the company is still in the hunt to provide an alternative to the liquid biopsy that was first to ...
The FDA approved the first at-home test for cervical cancer screening, developed by Teal Health. In clinical trials, the accuracy of self-testing with Teal's wand matched that of a cancer screening ...
In average-risk individuals, ColoSense demonstrated 93% sensitivity for detecting colorectal cancer (CRC) and 45% sensitivity for detecting advanced adenomas (AA). The CRC-PREVENT study evaluated more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results